Biotest AG banner

Biotest AG
OTC:BIESF

Watchlist Manager
Biotest AG Logo
Biotest AG
OTC:BIESF
Watchlist
Price: 32 USD Market Closed
Market Cap: $1.3B

Wall Street
Price Targets

BIESF Price Targets Summary
Biotest AG

There are no price targets for BIESF.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Biotest AG Competitors:
Price Targets
RCKT
Rocket Pharmaceuticals Inc
54% Upside
AKTIA
Aktia Bank Abp
4% Upside
OFIX
Orthofix Medical Inc
47% Upside
CYBR
Cyberark Software Ltd
21% Upside

Revenue
Forecast

7% / Year
Past Growth
-1% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
7% / Year
Past Growth
-1% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

For the last 8 years the compound annual growth rate for Biotest AG's revenue is 7%. The projected CAGR for the next 1 year is -1%.

Operating Income
Forecast

12% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
12% / Year
Past Growth
25% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

For the last 8 years the compound annual growth rate for Biotest AG's operating income is 12%. The projected CAGR for the next 1 year is 25%.

Net Income
Forecast

N/A
Past Growth
121% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat
N/A
Past Growth
121% / Year
Estimated Growth
Estimates Accuracy
1%
Average Beat

The compound annual growth rate of Biotest AG's net income for the next 1 year is 121%.

Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is BIESF's stock price target?
Not Available

BIESF doesn't have any price targets made by Wall Street professionals.

What is Biotest AG's Revenue forecast?
Projected CAGR
-1%

For the last 8 years the compound annual growth rate for Biotest AG's revenue is 7%. The projected CAGR for the next 1 year is -1%.

What is Biotest AG's Operating Income forecast?
Projected CAGR
25%

For the last 8 years the compound annual growth rate for Biotest AG's operating income is 12%. The projected CAGR for the next 1 year is 25%.

What is Biotest AG's Net Income forecast?
Projected CAGR
121%

The compound annual growth rate of Biotest AG's net income for the next 1 year is 121%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett